Dr. Lal Path Labs Ltd

IncreasedQuarterly

LALPATHLABHealthcareMarket Cap₹32K Cr

Stake

1.41% → 1.78%

Aditya Birla Sun Life Mutual Fund

Mutual Fund

The move

Aditya Birla Sun Life Mutual Fund increased its stake in Dr. Lal Path Labs Ltd from 1.41% to 1.78% by purchasing 6,16,676 shares. The value of these shares is ₹104.77 Cr at a price of ₹1699.00 apiece.

About Dr. Lal Path Labs Ltd

Visit stock

A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.

About Aditya Birla Sun Life Mutual Fund

Visit investor

Joint venture between Aditya Birla Capital and Sun Life Financial of Canada. Among India's top five AMCs with over Rs 6.5 lakh crore in AUM across 100+ schemes. MD and CEO A. Balasubramanian is one of the most outspoken fund industry voices in India. CIO Mahesh Patil oversees the equity book with a consistent large and multicap tilt.

Get the next move the moment it happens.

Follow Aditya Birla Sun Life Mutual Fund and Dr. Lal Path Labs Ltd on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Dr. Lal Path Labs Ltd shareholders Aditya Birla Sun Life Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Dr. Lal Path Labs Ltd

Tata Mutual Fund

Direction, size, price and stake change for this move, with what it means for the company.

11 Sept 2026. Sign in to see this move

SBI Mutual FundExited

SBI Mutual Fund is no longer on Dr. Lal Path Labs Ltd's list of disclosed shareholders, after its last reported stake of 1.65 percent, indicating either a complete sale or a reduction below the 1 percent disclosure threshold.